4-[(4-Bromophenyl)sulfanyl]-3-methyl-[1,2]oxazolo[5,4-d]pyrimidine

Catalog No. :
ACYTHG277
CAS No. :
478050-42-9
Molecular Formula :
C12H8BrN3OS
Molecular Weight :
322.19

IUPAC Name:4-((4-bromophenyl)thio)-3-methylisoxazolo[5,4-d]pyrimidine

4-[(4-Bromophenyl)sulfanyl]-3-methyl-[1,2]oxazolo[5,4-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[(4-Bromophenyl)sulfanyl]-3-methyl-[1,2]oxazolo[5,4-d]pyrimidine
IUPAC Name4-((4-bromophenyl)thio)-3-methylisoxazolo[5,4-d]pyrimidine
MDL No.MFCD01871531
Molecular FormulaC12H8BrN3OS
Molecular Weight322.19
SMILESCC1=NOC2=NC=NC(SC3=CC=C(Br)C=C3)=C21
InChI KeyARAJFNNRUIILLN-UHFFFAOYSA-N
Synonym4-[(4-BROMOPHENYL)SULFANYL]-3-METHYLISOXAZOLO[5,4-D]PYRIMIDINE;4-BROMOPHENYL 3-METHYLISOXAZOLO[5,4-D]PYRIMIDIN-4-YL SULFIDE;4-[(4-bromophenyl)sulfanyl]-3-methyl-[1,2]oxazolo[5,4-d]pyrimidine;Isoxazolo[5,4-d]pyrimidine, 4-[(4-bromophenyl)thio]-3-methyl-
CAS No.478050-42-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYTHG277 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYTHG277 route product structure diagram
    ACYTHG277478050-42-9
Inquiry

2. ACYTHG277 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYTHG277 route product structure diagram
    ACYTHG277478050-42-9
Inquiry

Comments (0)